Pieris Pharmaceuticals, Inc. ( PIRS) - Key Metrics
Stock symbol PIRS is outdated, potentially delisted? Maybe it is available on other exchange?
PIRS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | ? | -$2.19 | $0.11 | $0.11 |
| 2024Q2 | ? | -$2.76 | -$1.14 | -$1.14 |
| 2024Q1 | $0.04 | -$3.95 | -$5.66 | -$5.66 |
| 2023Q4 | $1.05 | -$3.71 | -$15.90 | -$15.89 |
| 2023Q3 | $15.80 | -$8.70 | -$7.87 | -$7.92 |
PIRS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -1.90 |
| 2024Q2 | ? | -0.88 |
| 2024Q1 | ? | -0.95 |
| 2023Q4 | ? | -0.98 |
| 2023Q3 | ? | -0.68 |
PIRS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | 0.67% | ? |
| 2024Q2 | -11.75% | ? |
| 2024Q1 | -37.80% | ? |
| 2023Q4 | -109.12% | ? |
| 2023Q3 | -33.24% | ? |
PIRS
Price: $13.60
52 week price:
Earnings Per Share: -12.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 522800
Ebitda: -5.1 millionMarket Capitalization: 21.9 million